The fallout over a $400 million fraud scheme by former ArthroCare (NSDQ:ARTC) executives continued yesterday after a national accounting board announced the suspension of the former PricewaterhouseCoopers accountant who audited ArthroCare’s books but failed to turn up the scheme.
ArthroCare Corp.
Convictions stand for ex-ArthroCare execs in $400M fraud scheme
A federal judge yesterday refused to overturn the convictions of 2 former ArthroCare (NSDQ:ARTC) executives found guilty last month of masterminding a scheme to defraud investors of some $400 million.
Olympus accuses ex-sales manager, ArthroCare | Medtech legal news for the week of June 23, 2014
Olympus goes after ex-sales manager, ArthroCare
Stryker suit alleges that DePuy helped sales reps defect from company | Medtech legal news for the week of June 9, 2014
Ex-ArthroCare execs convicted in $400M fraud case
A federal jury yesterday convicted 2 former ArthroCare (NSDQ:ARTC) executives, finding that the pair "masterminded and executed a scheme" to defraud investors of some $400 million, prosecutors said.
Ex-ArthroCare CEO, CFO must face $400M fraud charges
The former CEO and CFO for ArthroCare (NSDQ:ARTC) must face criminal fraud charges in Texas in an alleged $400 million scheme to dupe investors, after a federal judge this week shot down their bids for acquittal.